Commentary on ‘External Validation of Models Predicting Survival After Ruptured Abdominal Aortic Aneurysm Repair’  by De Rango, P.
Eur J Vasc Endovasc Surg (2015) 49, 17e18INVITED COMMENTARYCommentary on ‘External Validation of Models Predicting Survival After
Ruptured Abdominal Aortic Aneurysm Repair’
P. De Rango
Vascular and Endovascular Unit, Hospital S. Maria della Misericordia, Piazza Menghini, 1, 06132 Perugia, ItalyThe decision to palliate, that is to withhold potentially
effective treatment, is justiﬁed by the belief that the treat-
ment is of no beneﬁt and that it would carry excess mortality
risk. Nevertheless, concerns remain over when, why, and
whether palliating patients with abdominal aortic aneurysm
(AAA)makes sense, as the decision is still largely based on the
subjective interpretation of harsh reality. Critical appraisal of
sound evidence suggests that there are no reliable or valid
criteria to establish whether to treat an aneurysm in either
the elective or emergency situation. It has been suggested
that there will always be some patients at “highest risk,”
“unsuitable for intervention,” in whom the risk of elective
large AAA repair will outweigh potential survival beneﬁts.
Given that the likelihood of death from non-aneurysm
related causes is greater than that from the aneurysm it-
self, and that life expectancy would not increase despite
intervention, palliation should be offered to these patients.
However, how the “highest risk”or “unﬁtness” proﬁle should
be objectively and reliably measured, to withhold elective
aneurysm repair, remains debatable and not standardized.
Even more challenging is the decision to turn down pa-
tients with ruptured AAA (rAAA) as suggested in the paper
by the Amsterdam Acute Aneurysm Trial group (AIAX trial)
published in this issue of European Journal of Vascular and
Endovascular Surgery.1 Authors tested a number of well
known, already developed, predictive models, some reﬁned
for patients with rAAA, to identify subgroups at high mor-
tality risk, based on a variety of demographics, comorbidity,
and severity conditions (e.g. Hardman index, Vancouver
scoring system, updated Glasgow Aneurysm Score [GAS],
and Edinburgh Ruptured Aneurysm Score). Nevertheless,
the study showed only limited and insufﬁcient performance
of all the current prognostic models when applied to 449
real patients with rAAA treated in 10 Netherlands hospitals
in modern times (after 2004).1
Onemain ﬁnding derived from this validation study was the
general tendency to overestimate the true death rates ac-
cording to predicted values, and also using the updated GAS
model shown to be the most reliable and accurate in predic-
tion of death (60% in GAS vs. 54% observed death rate).DOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.10.012
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http://dx.doi.org/10.1016/j.ejvs.2014.10.019Even more relevant was the poor discrimination shown
by all the prognostic models in their ability to differentiate
the severity of disease and thereby to identify patients with
a predicted excess death rate (>95%) who might reasonably
be turned down for treatment. Besides the common
computable demographic and comorbidities, there are too
many more subtle and less measurable or ignored factors
that can affect the ability to survive or die for patients
presenting as an emergency with rAAA, especially nowa-
days, where the procedures can be performed endovascu-
larly with decreased mortality risks.
The messages of this paper are also of relevance because,
previously the same authors performed one of the few
randomized clinical trials (RCT) comparing open and endo-
vascular repair in rAAA (AIAX trial). This showed no differ-
ence in the 30 day mortality between two treatment groups
when applied in a randomized cohort. Even though two
other RCTs conﬁrmed clinical equipoise between EVAR and
open repair for rAAA as stated by the AIAX, other large non-
RCTs data all agreed on decreased (by about half) mortality
rate using the endovascular approach, as recently shown in
a large meta-analysis: pooled odds ratio for death was 0.44
(95% CI 0.37e0.53) in observational studies and 0.54 (95%
CI 0.47e0.62) in administrative studies.2 Critical appraisal of
evidence suggests that for acute settings of rAAA, RCTs may
not constitute the best evidence and more likely represent a
“failed experiment”: random assignment of treatment in
emergency AAA ruptures may be challenging and the
external validity (closeness to the truth), and thereby the
generalizability, of results obtained with random allocation
is poor. Using an individualized selected approach based on
judgment of suitability for an endo or open strategy
following a structured rAAA protocol seems a more
reasonable approach than any random strategy of treat-
ment for ruptured aneurysms.
In the validation study by the AIAX group,1 the ques-
tionable cumulative analysis of mortality regardless of the
endovascular or open procedure used for rAAA repair may
indeed represent a strength: observed mortality rates
would be even more reliable reﬂecting the current real
world practice where both endovascular and open strate-
gies are alternatively offered in patients with rAAA.
In summary, the endovascular approach has challenged
the accuracy, calibration, and discrimination ability of
prognostic models used to predict the mortality of AAA
18 P. De Rangorepair. At the time of AAA rupture, mortality is expected in
any patient if left untreated. Given the lower likelihood of
dying for many patients currently undergoing repair and the
failure to discriminate survivors by predictive prognostic
models, there may be no reasonable palliation today for
rAAA. The criteria for withholding intervention for rAAA
need to be revised and supported by sound and more
reliable data. When balancing the current risks and beneﬁts
of intervention for rAAA it is likely that only a few, if any,
denials will currently be justiﬁed.REFERENCES
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